6 Recruiting Oropharynx Cancer Phase 2 Clinical Trials
Active phase 2 studies for oropharynx cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Oropharynx Cancer studiesPhase 2 Studies for Oropharynx Cancer
🔵 Active, Not Recruiting Phase2
Neoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human Papilloma Virus Oropharynx Cancer)
📍 UC San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer
📍 University of Michigan Rogel Cancer Center — Ann Arbor, Michigan
View Study & Checklist ➔ 🟢 Recruiting Phase2
Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer
📍 Fox Chase Cancer Center — Philadelphia, Pennsylvania
View Study & Checklist ➔ 🟢 Recruiting Phase2
Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔ 🟢 Recruiting Phase2
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.
📍 McGill University Health Centre — Montreal, Quebec
View Study & Checklist ➔ 🟢 Recruiting Phase2
Adaptive RadioTherapy for OroPharynx Cancer
📍 Austin Health — Melbourne,
View Study & Checklist ➔